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Abstract
Mobile phone use has been discussed over the last few decades with increased risk for intracranial tumors. The
majority of studies have been conducted on gliomas and meningiomas. Although some case-control studies
have found a positive association between the use of mobile phones and the risk of tumors, other studies have
reported no significant association. A possible long-term mobile phone use may lead to increased risk however,
the evidences are not yet conclusive and further studies are needed. In the present study we reviewed the
current evidence for the association between mobile phone use and risk for intracranial tumors.
Background
Over the last three decades an increasing use of mobile
phones is evident worldwide. More than one billion of
mobile phone users have been reported to exist. The in-
creasing use of mobile phones has raised concerns of
health risk and especially for intracranial tumors, since
brain is the nearest organ than is in close contact with
the radiofrequency electromagnetic fields, emitted by
mobile phones. An even greater increased risk has been
suggested for children due to thinner skull, smaller head
and increased brain conductivity [1]. Nevertheless, other
studies have not verified this risk [2].
Apart from mobile use, cordless phones may be poten-
tially linked to increased risk of brain tumor. On 2011
the WHO International Agency for Research on Cancer
categorized radiofrequency electromagnetic fields from
mobile phones, and from other devices, as a Group 2B, a
possible human carcinogen [3, 4]. Investigation of the ef-
fects which RF may produce in cellular level in vivo and
in vitro revealed increased risk of cell death and cancer
development in mice. The potential effect of RF to germ
cells is worrisome since it can be transmitted to subse-
quent generations [5]. Nevertheless, a meta-analysis of
the available data on the genetic damage in human cells
exposed to non-ionizing radiofrequency fields revealed
no significant effect [6].
Among intracranial brain tumors in adults, meningi-
omas are the most common, accounting for 36 % of all,
followed by gliomas (28 %). Glioblastoma (WHO Grade
IV) is the most malignant primaty brain tumor, account-
ing for 15.7 % of all tumors. Other types are pituitary ad-
enomas (13.1 %), other neuroepithelial (5.1 %), lymphoma
(2.4 %), oligodendrogliomas (2 %), ependymomas (1.8 %),
embryonal tumors (1 %), craniopharyngioma (0.7 %) and
acoustic neuromas (0.6 %) [7]. Regarding pediatric brain
tumors, pilocytic astrocytoma is the most common tumor,
followed by medulloblastoma and ependymoma [8]. In the
present study we reviewed the current evidence on the
association between mobile phone use and risk for intra-
cranial tumor.
Material and methods
Criteria for study eligibility
We considered all English-language studies providing
original data on the association of mobile phone use and
risk for intracranial tumor that were published over the
last decade. We focused mainly on gliomas, meningi-
omas, acoustic neuromas and pituitary tumors, since few
evidence for other tumors exist [9]. All study designs
were eligible. We excluded articles with non original
data and duplicate publications.
Search strategy for identification of studies
PubMed searches were performed using a wide array of
terms pertinent to mobile phone use and intracranial
tumor. The exact search (last updated in September 2015)
is available from the authors upon request. Moreover, the
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reference lists of eligible articles and pertinent reviews
were scrutinized. Retrieved articles were evaluated for eli-
gibility by two independent investigators and disagree-
ments were solved by consensus. From each eligible study,
we extracted the following information: author; journal;
year; design; study population and details on the defini-




The electronic literature search yielded 439 items. Of those,
387 were irrelevant to the project based on examination of
the title and abstract, while 52 articles were relevant or
their relevance could not be decided upon examining
the title and abstract. The 52 articles were examined in
full-text and 22 met the inclusion eligibility criteria
(Fig. 1) [2, 9–29]. There were two cohort studies of mo-
bile phone users and 20 case-control studies on this
topic. Reasons for exclusion were no original data (n = 26)
and duplicate/overlapping data (n = 4).
Gliomas
Several studies have investigated whether mobile phone
use is associated with an increased risk for gliomas
[10–16]. Nevertheless, the results are still not conclu-
sive. A recent study analysis of two case-control stud-
ies, on malignant brain tumors, that included 1498
cases and 3530 controls, revealed that mobile phone
use increased the risk of glioma. The risk was nearly
double in the group with over 25 years latency period.
An increased risk was also found for the cordless phone
use. Furthermore, in the same study it was of note the
finding that temporal lobe had the highest risk for
glioma occurrence [17]. Another case-control study,
conducted in France, that included 253 gliomas, 194
meningiomas and 892 matched controls, revealed no
association between mobile phone use and risk for gli-
omas. Nevertheless, in heavy mobile phone users with
cumulative duration over 896 h or number of calls over
18,600 there was a significant increased risk for glioma
[14]. A decreased survival of glioma patients with long-
term use of wireless phones has been also recently re-
ported [30]. In low grade gliomas, although mobile
phone use has been associated with increased risk,
when focusing on survival, a survival benefit was re-
ported in low grade glioma patients with mobile phone
use. The authors hypothesis was that tumor volume
was larger in exposed than in unexposed patients,
which would permit an earlier diagnosis and surgical
Fig. 1 Flow chart of study selection
Table 1 Odds ratios (ORs) and 95 % confidence intervals (CIs) from case–control studies on gliomas
Study No of Cases No of Control OR (95 % CI)
Hardell et al. 2015 [17] 1.498 3.530 1.3 (1.1–1.6)
Coureau et al. 2014 [14] 253 892 1.24 (0.86–1.77)
Hardell et al. 2013 [15] 593 1368 1.6 (0.99–2.77)
Aydin et al. 2011 [2] 352 646 1.36 (0.92–2.20)
Cardis et al. 2011 [16] 553 1.762 0.93 (0.73–1.18)
Hardell et al. 2010 [19] 346 276 2.4 (1.4–4.1)
INTERPHONE Study 2010 [20] 2.708 2.972 0.81 (0.70–0.94)
Klaeboe et al. 2007 [10] 96 227 0.8 (0.5–1.1)
Takebayashi et al. 2008 [23] 88 118 0.7 (0.4–1.2)
Hepworth et al. 2006 [31] 966 1.717 0.94 (0.78–1.13)
Christensen et al. 2005 [12] 83 193 0.66 (0.46–0.95)
Lönn et al. 2005 [13] 371 674 0.73 (0.55–0.96)
Alexiou and Sioka Journal of Negative Results in BioMedicine  (2015) 14:23 Page 2 of 5
intervention [30]. In 2010 Hardell et al reported an in-
creased risk for glioma for both short and long term
mobile phone users. Nevertheless, one possibly bias of
this study was that for deceased patients, data on ex-
posure were collected from relatives up to 11 years
after death [19]. Hardell et al included patients 20–80
years [19]. This is important since the highest incidence
of glioblastoma, the most common and malignant brain
tumor, is found in the age group 45–75 years.
The largest study conducted to date was the INTER-
PHONE study, which was conducted in 13 countries
with 16 centers. This was an interview-based case-
control study and involved 2409 meningioma, 2708 gli-
oma cases and matched controls. The studies included
patients 30–59 years. The results showed the absence of
increased risk of glioma with use of mobile phones.
There was suspicious of an increased risk of glioma at
the highest exposure levels, but further investigation is
needed in order to draw safe conclusions [20]. It is of
note that the overall ORs in some of the included studies
were <1.0, suggesting possible methodological drawbacks.
In fact in the studies included in the INTERPHONE study
no blinding was used. Finally a large prospective study
that investigated the association of mobile phone use and
incidence of intracranial tumors and other cancers in
791,710 middle-aged women in UK found no appreciable
association for glioma or meningioma [28]. A Danish
cohort study that included 358,403 subscription holders
accrued 3.8 million person years found no increased risk
for glioma even for individuals with more than 13 years of
subscription [29]. Other older studies also showed no
strong relation between mobile phone use and gliomas
(Table 1) [10–16].
Meningiomas
In meningiomas 8 case control studies were identified
(Table 2) [9–11, 13, 14, 16, 18, 20]. A pooled analysis of
two Swedish case-control studies on 1625 meningioma
patients and 3530 control patients showed a relative in-
creased risk (OR = 1.2, CI = 0.9–1.6) among heavy users
of mobile and cordless phones [18]. The INTERPHONE
study that has been analyzed previously, reported no in-
creased risk of meningioma in individuals that used a
mobile phone [20]. Similarly, in the Danish cohort study,
among those with mobile phone subscriptions of over
10 years, the risk ratios were 0.90 (0.57 to 1.42) in men
and 0.93 (0.46 to 1.87) in women for meningioma [29].
Further evidence on absence of association between
meningioma occurrence and mobile phone use have
been provided by the study in five North European
countries [10]. The results showed no increased risk in
relation to years since first use, lifetime years of use, cu-
mulative hours of use or cumulative number of calls
[10]. Since meningioma is a slow-growing tumor, longer
Table 2 Odds ratios (ORs) and 95 % confidence intervals (CIs) from case-control studies on meningiomas
Study No of Cases No of Control OR (95 % CI)
Carlberg et al. 2015 [18] 1.625 3.530 1.2 (0.9–1.6)
Coureau et al. 2014 [14] 194 892 0.90 (0.61–1.34)
Cardis et al. 2011 [16] 676 1.911 0.80 (0.66–0.96)
INTERPHONE Study 2010 [20] 2.409 2.662 0.83 (0.61–1.14)
Lahkola et al. 2008 [9] 1.204 2.945 0.76 (0.65–0.89)
Takebayashi et al., 2008 [23] 132 229 0.70 (0.42–1.16)
Klaeboe et al. 2007 [10] 207 358 1.2 (0.6–2.2)
Lönn et al. 2005 [13] 273 674 0.7 (0.5–0.9)
Table 3 Odds ratios (ORs) and 95 % confidence intervals (CIs) from case-control studies on acoustic neuromas and pituitary tumors
Study No of Cases No of Control OR (95 % CI)
Acoustic neuroma
Pettersson et al. 2014 [27] 451 710 1.18 (0.88–1.59)
Hardell et al. 2013 [24] 316 3.530 1.6 (1.2–2.2)
Schlehofer et al. 2007 [21] 97 194 0.67 (0.38–1.19)
Schoemaker et al. 2005 [25] 678 3.553 0.9 (0.7–1.1)
Pituitary Tumors
Shrestha et al. 2015 [22] 80 240 0.39 (0.21–0.72)
Schoemaker et al. 2009 [26] 291 630 0.9 (0.7–1.3)
Takebayashi et al. 2008 [23] 102 683 0.90 (0.50–1.61)
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latency period is obviously needed in order to draw de-
finitive conclusions.
Acoustic neuroma
Acoustic neuromas are also slow-growing tumors, thus
observation period should not be short. For acoustic neur-
oma, a large prospective study reported an increased risk
with long term use compared to patients who never used
a mobile phone. Furthermore, the risk increased with in-
creased duration of use [28]. The results of the INTER-
PHONE study on acoustic neuroma showed no increased
risk in the first decade after starting mobile phone use
[21]. Risk of a tumor on the same side of the head as the
reported phone use was increased only for use over
10 years (OR = 1.8, 95 % CI: 1.1–3.1) [21]. In a population-
based case-control study in Germany that investigated the
risk factors in 97 acoustic neuromas and 194 matched
controls, no increased risk was found in regular phone use
(OR = 0.67; 95 % CI 0.38–1.19) [20] (Table 3).
Pituitary tumors
Regarding the relationship between development of pituit-
ary tumors and mobile phone use, a recent case-control
study that included 80 cases and 240 matched controls re-
vealed no increase in pituitary tumor risk even after 10 or
more years of usage. The risk was not influenced by call’s
duration, hours of usage or cumulative number of calls.
No difference was found for analog and digital phones
[22]. A previous study that included 88 gliomas, 132 men-
ingiomas, 102 pituitary adenomas and 683 individually
matched controls evaluated the SAR inside the tumor. All
maximal SAR values were below the levels at which ther-
mal effects occurs. The results showed no overall increase
in OR and there was no significant trend towards an in-
creasing OR in relation to SAR [23] (Table 3).
Conclusion
Although some small studies have showed a connection
between intracranial tumors occurrence and mobile
phone usage, this effect was not verified in larger series.
The fact that some studies showed a reduced cancer
risk, from biological point of view is difficult to believe
that microwave exposure prevent brain tumors, thus
possible metholodological errors in these studies should
be sought. Furthermore, random errors or selection bias
cannot be excluded in these studies [31]. Nevertheless,
there was some evidence to suggest a connection between
heavy mobile phone use and increased risk for brain
tumor occurrence, especially for gliomas. Nevertheless,
further studies are needed to study the possibility of long
term use and gliomas. For meningiomas, acoustic neur-
omas and pituitary tumors the results are inconclusive.
Thus, there is certainly a need for more studies and con-
tinuous surveillance.
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